PLUR

Pluri Inc.

0.77 USD
+0.02 (+3.31%)
Last updated
This page is just a preview of the data found in TrendSpider’s full version

Pluri Inc. stock is up 17.24% since 30 days ago. The next earnings date is Sep 12, 2023. The company has had below-average volume in the last 30 days. Its seasonality going into this month shows a chance of a green month, as 47.62% of the previous 20 February’s closed higher than January.

About Pluri Inc.

Pluristem Therapeutics Inc. focuses on the research, development, clinical trial, and manufacture of cell therapeutic products and related technologies. The company develops placental expanded (PLX) based cell therapy products, including PLX-PAD that is in Phase III clinical trial for the recovery after surgery for hip fracture.